Literature DB >> 3416433

Simultaneous determination of carbamazepine and its epoxide and transdiol metabolites in plasma by microbore liquid chromatography.

L E Riad1, R J Sawchuk.   

Abstract

Simultaneous monitoring of carbamazepine and its metabolities is helpful in providing information on the induction process via the epoxide-diol route. The present method involves the liquid-chromatographic analysis of 1.0 mL of plasma for carbamazepine at concentrations of 0.025 to 4.0 mg/L and for both the 10,11-epoxide and 10,11-transdiol metabolites at concentrations of 0.01 to 1.0 mg/L. Weighted regression equations, expressing peak area ratios as a function of concentrations of carbamazepine and its epoxide and transdiol metabolites in the standards, were used to determine concentrations in plasma samples.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3416433

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  The bioinequivalence of carbamazepine tablets with a history of clinical failures.

Authors:  M C Meyer; A B Straughn; E J Jarvi; G C Wood; F R Pelsor; V P Shah
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

2.  Absorptive clearance of carbamazepine and selected metabolites in rabbit intestine.

Authors:  L E Riad; R J Sawchuk
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

3.  The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets.

Authors:  M C Meyer; A B Straughn; R M Mhatre; V P Shah; R L Williams; L J Lesko
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

4.  Effect of polyethylene glycol 400 on the intestinal permeability of carbamazepine in the rabbit.

Authors:  L E Riad; R J Sawchuk
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

Review 5.  Quantitative bioanalytical and analytical method development of dibenzazepine derivative, carbamazepine: A review.

Authors:  Prasanna A Datar
Journal:  J Pharm Anal       Date:  2015-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.